A phase 1 trial of CAR T-cell therapy in patients with folate-receptor positive osteosarcoma.
Phase of Trial: Phase I
Latest Information Update: 10 Nov 2017
At a glance
- Drugs CAR-T cell therapies (Primary)
- Indications Osteosarcoma
- Focus Adverse reactions
- 10 Nov 2017 New trial record
- 06 Nov 2017 According to Endocyte media release, the IND filing of the drug is anticipated in 2018 and the initiation of trial is planned in 2nd half of 2018.